In vivo experiments: Utilizing humanized or immunocompetent IBC mouse models to evaluate the effects of SPP1 knockout or anti-SPP1 neutralizing antibodies, as well as depletion of pDCs or inhibition of their GZMB activity, on tumor growth, metastasis, and treatment response. Here, SPP1 is linked to neoplasm.